NAD+observational2019

Chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside.

Organic & biomolecular chemistry

confidence

Key findings

Developed chemo-enzymatic synthesis of isotopically labeled nicotinamide riboside (NR); NR is efficiently converted to NAD+ in cellular environment independent of degradation to nicotinamide.

View source on PubMed (PMID 29714801) ↗

Population
In vitro / cellular environment
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

As a cofactor for numerous reactions, NAD+ is found widely dispersed across many maps of cellular metabolism. This core redox role alone makes the biosynthesis of NAD+ of great interest. Recent studies have revealed new biological roles for NAD+ as a substrate for diverse enzymes that regulate a broad spectrum of key cellular tasks. These NAD+-consuming enzymes further highlight the importance of understanding NAD+ biosynthetic pathways. In this study, we developed a chemo-enzymatic synthesis of isotopically labeled NAD+ precursor, nicotinamide riboside (NR). The synthesis of NR isotopomers allowed us to unambiguously determine that NR is efficiently converted to NAD+ in the cellular environment independent of degradation to nicotinamide, and it is incorporated into NAD+ in its intact form. The versatile synthetic method along with the isotopically labeled NRs will provide powerful tools to further decipher the important yet complicated NAD+ metabolism.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.